These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 9930070

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer.
    Koukourakis MI, Giatromanolaki A, Guddo F, Kaklamanis L, Vignola M, Kakolyris S, Turley H, Georgoulias V, Bonsignore G, Gatter KC, Harris AL.
    J Immunother; 2000 Jan; 23(1):104-14. PubMed ID: 10687143
    [Abstract] [Full Text] [Related]

  • 3. Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.
    Giatromanolaki A, Koukourakis MI, O'Byrne K, Kaklamanis L, Dicoglou C, Trichia E, Whitehouse R, Harris AL, Gatter KC.
    Anticancer Res; 1996 Jan; 16(6B):3819-25. PubMed ID: 9042264
    [Abstract] [Full Text] [Related]

  • 4. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
    Onn A, Correa AM, Gilcrease M, Isobe T, Massarelli E, Bucana CD, O'Reilly MS, Hong WK, Fidler IJ, Putnam JB, Herbst RS.
    Clin Cancer Res; 2004 Jan 01; 10(1 Pt 1):136-43. PubMed ID: 14734462
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Hsp90AB1 Protein is Overexpressed in Non-small Cell Lung Cancer Tissues 
and Associated with Poor Prognosis in Lung Adenocarcinoma Patients].
    Wang M, Feng L, Li P, Han N, Gao Y, Xiao T.
    Zhongguo Fei Ai Za Zhi; 2016 Feb 01; 19(2):64-9. PubMed ID: 26903158
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC.
    Clin Cancer Res; 1998 Dec 01; 4(12):3017-24. PubMed ID: 9865915
    [Abstract] [Full Text] [Related]

  • 8. C-erbB-3 expression in non-small cell lung cancer (NSCLC) patients treated by Erlotinib.
    CsToth I, Anthoine G, Berghmans T, Mascaux C, Paesmans M, Sculier JP, Meert AP.
    Anticancer Res; 2011 Jan 01; 31(1):281-5. PubMed ID: 21273611
    [Abstract] [Full Text] [Related]

  • 9. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, Harris AL.
    Cancer Res; 2001 Nov 01; 61(21):7992-8. PubMed ID: 11691824
    [Abstract] [Full Text] [Related]

  • 10. Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4.
    Lodge AJ, Anderson JJ, Gullick WJ, Haugk B, Leonard RC, Angus B.
    J Clin Pathol; 2003 Apr 01; 56(4):300-4. PubMed ID: 12663644
    [Abstract] [Full Text] [Related]

  • 11. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
    Grossi F, Spizzo R, Bordo D, Cacitti V, Valent F, Rossetto C, Follador A, Di Terlizzi S, Aita M, Morelli A, Fasola G, Consiglieri C, Ceschia T, Beltrami CA, Belvedere O.
    J Thorac Oncol; 2010 Sep 01; 5(9):1354-60. PubMed ID: 20631638
    [Abstract] [Full Text] [Related]

  • 12. C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.
    Giatromanolaki A, Gorgoulis V, Chetty R, Koukourakis MI, Whitehouse R, Kittas C, Veslemes M, Gatter KC, Iordanoglou I.
    Anticancer Res; 1996 Sep 01; 16(2):987-93. PubMed ID: 8687165
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.
    Al-Saad S, Al-Shibli K, Donnem T, Andersen S, Bremnes RM, Busund LT.
    J Thorac Oncol; 2010 Oct 01; 5(10):1536-43. PubMed ID: 20802349
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of the C-erbB-2 expression in turkish non-small cell lung cancer patients.
    Calikusu Z, Yildirim Y, Akcali Z, Sakalli H, Bal N, Ozyilkan O.
    Asian Pac J Cancer Prev; 2009 Oct 01; 10(3):479-82. PubMed ID: 19640195
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W.
    Hum Pathol; 2008 Jan 01; 39(1):126-36. PubMed ID: 17949785
    [Abstract] [Full Text] [Related]

  • 16. Sialomucin expression is associated with erbB-2 oncoprotein overexpression, early recurrence, and cancer death in non-small-cell lung cancer.
    Yu CJ, Shun CT, Yang PC, Lee YC, Shew JY, Kuo SH, Luh KT.
    Am J Respir Crit Care Med; 1997 Apr 01; 155(4):1419-27. PubMed ID: 9105088
    [Abstract] [Full Text] [Related]

  • 17. Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients.
    Kanematsu T, Yano S, Uehara H, Bando Y, Sone S.
    Oncol Res; 2003 Apr 01; 13(5):289-98. PubMed ID: 12688680
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
    Langer R, Von Rahden BH, Nahrig J, Von Weyhern C, Reiter R, Feith M, Stein HJ, Siewert JR, Höfler H, Sarbia M.
    J Clin Pathol; 2006 Jun 01; 59(6):631-4. PubMed ID: 16731604
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome.
    Koutsopoulos AV, Mavroudis D, Dambaki KI, Souglakos J, Tzortzaki EG, Drositis J, Delides GS, Georgoulias V, Stathopoulos EN.
    Lung Cancer; 2007 Aug 01; 57(2):193-200. PubMed ID: 17442448
    [Abstract] [Full Text] [Related]

  • 20. EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.
    Suo Z, Risberg B, Kalsson MG, Willman K, Tierens A, Skovlund E, Nesland JM.
    J Pathol; 2002 Jan 01; 196(1):17-25. PubMed ID: 11748637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.